Nanexa AB (NANEXA) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.175x

Based on the latest financial reports, Nanexa AB (NANEXA) has a cash flow conversion efficiency ratio of 0.175x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr17.79 Million ≈ $1.91 Million USD) by net assets (Skr101.53 Million ≈ $10.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Nanexa AB - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Nanexa AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read NANEXA total liabilities for a breakdown of total debt and financial obligations.

Nanexa AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanexa AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
LiveOne Inc NASDAQ:LVO	0.215x
SGC eTEC E&C Co. Ltd KQ:016250	-0.045x
Chien Shing Stainless Steel Co Ltd TW:2025	0.004x
Tplex Co. Ltd KQ:081150	0.005x
Lunnon Metals Ltd AU:LM8	-0.119x
TMP Steel TWO:6248	0.075x
Itera ASA OL:ITERA	-0.143x
Gseven Co Ltd TWO:2937	0.104x

Annual Cash Flow Conversion Efficiency for Nanexa AB (2014–2025)

The table below shows the annual cash flow conversion efficiency of Nanexa AB from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Nanexa AB (NANEXA) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr101.53 Million ≈ $10.93 Million	Skr-1.46 Million ≈ $-157.33K	-0.014x	+96.14%
2024-12-31	Skr70.92 Million ≈ $7.63 Million	Skr-26.43 Million ≈ $-2.84 Million	-0.373x	+16.29%
2023-12-31	Skr95.83 Million ≈ $10.31 Million	Skr-42.66 Million ≈ $-4.59 Million	-0.445x	-516.99%
2022-12-31	Skr109.10 Million ≈ $11.74 Million	Skr-7.87 Million ≈ $-847.05K	-0.072x	+56.56%
2021-12-31	Skr151.29 Million ≈ $16.28 Million	Skr-25.13 Million ≈ $-2.70 Million	-0.166x	+57.21%
2020-12-31	Skr43.35 Million ≈ $4.67 Million	Skr-16.83 Million ≈ $-1.81 Million	-0.388x	-2.54%
2019-12-31	Skr24.88 Million ≈ $2.68 Million	Skr-9.42 Million ≈ $-1.01 Million	-0.379x	+8.75%
2018-12-31	Skr16.29 Million ≈ $1.75 Million	Skr-6.76 Million ≈ $-727.11K	-0.415x	-124.54%
2017-12-31	Skr27.46 Million ≈ $2.95 Million	Skr-5.07 Million ≈ $-545.87K	-0.185x	+51.07%
2016-12-31	Skr16.96 Million ≈ $1.83 Million	Skr-6.41 Million ≈ $-689.32K	-0.378x	+30.46%
2015-12-31	Skr6.07 Million ≈ $652.70K	Skr-3.29 Million ≈ $-354.41K	-0.543x	-241.43%
2014-12-31	Skr1.47 Million ≈ $158.09K	Skr563.99K ≈ $60.69K	0.384x	--

About Nanexa AB

ST:NANEXA Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$60.08 Million

Skr558.32 Million SEK

Market Cap Rank

#21180 Global

#383 in Sweden

Share Price

Skr3.43

Change (1 day)

+2.39%

52-Week Range

Skr1.60 - Skr4.92

All Time High

Skr15.20